Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to evaluate the efficacy and safety of human amniotic epithelial cells transplant in nonunion of limb fracture patients.


Clinical Trial Description

In this study, patients of nonunion after limb fracture will be treated with human amniotic epithelial cells. Clinical and radiological assessment is performed.

hAECs developing from the epiblast as early as 8 days after fertilization, recent data reported indicate that hAECs possess proper osteogenic differentiation potential and a localized modulatory influence on the early tissue remodeling process, making these cells a promising stem cell source for bone regeneration after fractures. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03031509
Study type Interventional
Source Shanghai East Hospital
Contact Xia LI, Dr.
Phone 86-21-38804518
Email daxia868@163.com
Status Not yet recruiting
Phase Phase 1/Phase 2
Start date December 2017
Completion date December 2020

See also
  Status Clinical Trial Phase
Withdrawn NCT01429012 - Treatment of Atrophic Nonunion Fractures by Autologous Mesenchymal Stem Cell Percutaneous Grafting Phase 2
Completed NCT01788059 - The Efficacy of Mesenchymal Stem Cells for Stimulate the Union in Treatment of Non-united Tibial and Femoral Fractures in Shahid Kamyab Hospital Phase 2